Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M COOPER

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2016
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response PhenotypesD M Rotroff, M H Shahin, S B Gurley, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Obesity Science & Practice|August 29, 2018
Characterization of adult obesity in Florida using the OneFlorida clinical research consortiumS L Filipp, M Cardel, J Hall, et al.
Anaesthesia|August 17, 2022
Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societiesN Chrimes, A Higgs, C A Hagberg, et al.
Clinical Pharmacology and Therapeutics|June 12, 2014
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 updateL B Ramsey, S G Johnson, K E Caudle, et al.
The Pharmacogenomics Journal|August 22, 2012
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatmentJ H Karnes, C W McDonough, Y Gong, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2016
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response PhenotypesD M Rotroff, M H Shahin, S B Gurley, et al.
Journal of Internal Medicine|March 12, 2014
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses studyA G Vandell, C W McDonough, Y Gong, et al.
Obesity Science & Practice|August 29, 2018
Characterization of adult obesity in Florida using the OneFlorida clinical research consortiumS L Filipp, M Cardel, J Hall, et al.
Anaesthesia|August 17, 2022
Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societiesN Chrimes, A Higgs, C A Hagberg, et al.
Clinical Pharmacology and Therapeutics|June 12, 2014
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 updateL B Ramsey, S G Johnson, K E Caudle, et al.
The Pharmacogenomics Journal|August 22, 2012
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatmentJ H Karnes, C W McDonough, Y Gong, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Pageof 8